Rossi Michael A.
Known title: Chief Financial OfficerCIK: 0001783869
Associated companies
Transaction History
| HBIO | ▼ Sell | Tax Withholding | 3,162 | $8K | 12/29/2022 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 3,763 | $10K | 12/29/2022 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 3,035 | $8K | 12/29/2022 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 7,008 | $25K | 7/18/2022 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 6,325 | $25K | 6/11/2022 | View on chart |
| HBIO | ▲ Buy | Grant | 31,021 | $0 | 3/1/2022 | View on chart |
| HBIO | ▲ Buy | Grant | 28,716 | $0 | 3/1/2022 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 3,163 | $23K | 12/29/2021 | View on chart |
| HBIO | ▼ Sell | Tax Withholding | 3,763 | $27K | 12/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Harvard Bioscience Forms Scientific Advisory Board
Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.
Harvard Bioscience Forms Scientific Advisory Board. Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.